Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 30, 2021 12:35 ET | Source: The Law Offices of Frank R. Cruz

DEADLINE ALERT for KPLT, HYRE, and SAVA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, Sept. 30, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
September 30, 2021 12:31 ET | Source: Float, Dubai

Float Dubai Prepares to Launch on Its Voyage as The World’s Largest Floating Nightclub

Dubai, UAE, Sept. 30, 2021 (GLOBE NEWSWIRE) -- The nightlife scene in Dubai is set to get a whole lot wetter as the world’s largest floating nightclub dubbed ‘Float Dubai’ is set to embark on its...
September 30, 2021 12:30 ET | Source: ReportLinker

The global Chlor-Alkali market size is estimated to be USD 63.2 billion in 2021 and is projected to reach USD 77.4 billion by 2026, at a CAGR of 4.1% between 2021 and 2026

New York, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Chlor-Alkali Market by Type, Region - Global Forecast to 2026" -...
September 30, 2021 12:30 ET | Source: Faruqi & Faruqi LLP

HYZON INVESTOR ALERT: Faruqi & Faruqi LLP, Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Hyzon To Contact Him Directly To Discuss Their Options

NEW YORK, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hyzon Motors Inc. (“Hyzon” or the “Company”)...
September 30, 2021 12:30 ET | Source: OSE Immunotherapeutics

Boehringer Ingelheim and OSE Immunotherapeutics Announce First Patient Dosed in Phase 1 Expansion Trial of SIRPα Antagonist Monoclonal Antibody BI 765063 in combination with anti-PD-1 Antibody Ezabenlimab, in Patients with Advanced Endometrium or Colorectal Tumors

Dosing of first patient in the expansion phase triggers a milestone payment of €8 million from Boehringer Ingelheim to OSE Immunotherapeutics.Data from the dose escalation Step 1 of the Phase 1 trial...
September 30, 2021 12:30 ET | Source: IVALIS

Mise à disposition du Rapport Annuel au 31 mars 2021

IVALISInformations FinancièresMontigny, le 30 septembre 2021 après bourse Mise à disposition du Rapport Annuel au 31 mars 2021 Le groupe IVALIS a mis aujourd'hui à la disposition du public et déposé...
September 30, 2021 12:30 ET | Source: PROLOGUE

Prologue - Résultats opérationnels nettement supérieurs au niveau d'avant crise

RÉSULTATS OPÉRATIONNELS NETTEMENT SUPÉRIEURS AU NIVEAU D’AVANT CRISE FORTE CROISSANCE DU RÉSULTAT OPÉRATIONNEL COURANT PAR RAPPORT AU S1 20192,6 M€ DE FLUX DE TRÉSORERIE OPÉRATIONNELLE POSITIF...
September 30, 2021 12:30 ET | Source: Downing ONE VCT plc

Total voting rights

Downing ONE VCT plc LEI: 213800R88MRC4Y3OIW86Total Voting Rights30 September 2021 In conformity with the Disclosure and Transparency Rule 5.6.1, Downing ONE VCT plc announces that the Company’s...
September 30, 2021 12:30 ET | Source: Draper Esprit VCT plc

Total voting rights

Draper Esprit VCT plc Legal Entity Identifier: 2138003I9Q1QPDSQ9Z97 Total Voting Rights 30 September 2021 In conformity with the Disclosure and Transparency Rule 5.6.1, Draper Esprit VCT...
September 30, 2021 12:30 ET | Source: Glancy Prongay & Murray LLP

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ATI Physical Therapy f/k/a Fortress Value Acquisition Corp. II (ATIP, FVAC)

LOS ANGELES, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 15, 2021 deadline to file a lead plaintiff motion in the class...

1 ...100481 100482 100483 ...326067